Stay updated on Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi
Sign up to get notified when there's something new on the Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi page.

Latest updates to the Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi page
- CheckyesterdayChange DetectedA plain-language summary of the SAVANNAH study has been added to the Study Details page, outlining the rationale and design of combining osimertinib with savolitinib in EGFRm+/MET+ NSCLC after progression on osimertinib. The previous plain-language summary citation line has been removed/updated to reflect the new entry.SummaryDifference0.0%

- Check8 days agoChange DetectedThe page's revision tag was updated to v3.6.5, replacing the previous v3.6.4 tag to reflect a newer version.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedA new plain-language publication citation for the SAVANNAH study was added, and the page revision is updated to v3.6.4, replacing v3.6.3.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page now shows Revision: v3.6.3 and no longer displays Revision: v3.6.0, indicating a small metadata update to the study record page.SummaryDifference0.0%

- Check59 days agoChange DetectedNo additions or deletions are detected in the provided data, so the page content remains as described in the given context.SummaryDifference0.0%

- Check66 days agoChange DetectedRecruitment messaging now shows 'No longer looking for participants' and new help/navigation sections were added during the page update. The Intervention/Treatment heading formatting was adjusted and the revision label updated to v3.6.0 (replacing v3.5.5).SummaryDifference0.2%

Stay in the know with updates to Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi page.